Rebuilding pharma supply chains

Donald Trump says he wants more of the medicines US patients use to be manufactured within the US. And to make that happen, he’s brandishing both stick and carrot. He has threatened punitive tariffs on pharmaceutical imports, and on 5 May signed an executive order aimed at lowering barriers to companies wanting to build new pharmaceutical plants in the US, while increasing inspection fees and tightening regulatory enforcement on foreign producers.